Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System – LiverSafe 3D™ 

 

 

VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System – LiverSafe 3D™

November 13, 2012 - (VistaGen) - "VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced a significant advance in its development of LiverSafe 3D™, a human liver cell-based bioassay system designed to predict liver toxicity and drug metabolism issues in connection with the Company’s drug rescue activities."  Read Full Article

 

Posted on 27-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: